Table 1.

Patient cohort overview.

Patient #	Diagnosis	Age at inclusion	Sex	Biopsy site	Days between cfDNA & tDNA sampling	cfDNA concentration (ng/ml plasma)	Days treatment-cfDNA sampling	tDNA status
Patient 1	Stomach c.	65	M	Liver	0	58.03		Known
Patient 2	Cholangiocarcinoma	34	M	Liver	0	202.13		Known
Patient 3	Pancreas c.	58	F	Liver	0	29.01		Known
Patient 4	Oesophagus c.	83	M	Liver	0	191.13		Known
Patient 5	Lung c.	60	M	Lymph node	96	10.63		Known
Patient 6	Colon c.	50	F	Stomach	0	65.31	In treatment	Known
Patient 7	Breast c.	60	F	Skin	0	5.6		Known
Patient 8	Colon c.	74	F	Liver	0	41.39		Unknown
Patient 9	Cervix c.	35	F	Lymph node	0	8.31		Unknown
Patient 10	Colon c.	64	M	Liver	0	27.23		Unknown

Age: Age at the inclusion to CoPPO study.

Days after last treatment: Days after the last treatment has been given.